NTOX-14. THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

BACKGROUND: Immune checkpoint blockade has shown significant antitumor responses and is approved for the treatment of multiple cancer types. Immune checkpoint inhibitors (ICI) are associated with a unique set of toxicities termed irAEs. This study seeks to review the incidence and clinical manifesta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Malani, Rachna, Haggiagi, Aya, Holder, Jenessa, Shames, Yelena, Briggs, Samuel, Santomasso, Bianca, Callahan, Margaret
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692525/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars